In 2022, Drug Hunter highlighted 120 Molecules of the Month with structures or stories that were published for the first time, were approved or disclosed new significant data. They were selected from tens of thousands of research articles published by leading institutions from around the world. Here is the final list of the top 10 candidates for 2022’s Molecule of the Year, nominated by our readers and reviewers. It's always incredibly hard to narrow down the group, and even harder to pick just one! These finalists are selected based on a variety of factors. There are four first-in-class compounds, the first approved de novo deuterated API, a preclinical, non-hormonal male contraceptive agent, a possible accelerated approval for the challenging-to-treat NASH, and more molecules with interesting and unique properties to choose from!
Molecules of the Year Nominees
- BMS TYK2 inhibitor
- Mirati/Array/Pfizer KRAS(G12D) inhibitor
- Madrigal THRβ-selective agonist
- GBT/Pfizer HbS polymerization inhibitor
- Myokardia/BMS cardiac myosin inhibitor
- Kura Oncology menin-MLL1 inhibitor
- LEO Pharma IL-17A modulator
- YourChoice/UMN RAR-α antagonist
- Cerevel/Pfizer M4 positive allosteric modulator
- ChemoCentryx C5aR antagonist
- BMS TYK2 inhibitor
- Mirati/Array/Pfizer KRAS(G12D) inhibitor
- Madrigal THRβ-selective agonist
- GBT/Pfizer HbS polymerization inhibitor
- Myokardia/BMS cardiac myosin inhibitor
- Kura Oncology menin-MLL1 inhibitor
- LEO Pharma IL-17A modulator
- YourChoice/UMN RAR-α antagonist
- Cerevel/Pfizer M4 positive allosteric modulator
- ChemoCentryx C5aR antagonist
Molecules of the Month
Molecules of the Month
Nominate a molecule
Saw an interesting case study recently? Share it with the community!
Become a reviewer
Interested in helping assess new topics and providing scientific input? Get connected!
Join the Drug Hunter Mailing List
to get free content and resources weekly. Trusted by >15,000 drug hunters worldwide. Unsubscribe anytime.
Popular Content
- 1.2023 Novel Small Molecule FDA Drug Approvals
- 2.Top 12 Most Popular Drug Hunter Case Studies of 2023
- 3.Top Ten Most Popular Drug Hunter Resources of 2023
- 4.Top 10 Most Popular Drug Hunter Review Articles of 2023
- 5.Practical PK Calculators
- 6.AACR Orlando 2023: New Drug Candidates
- 7.PK Cheat Sheet
- 8.Phase I Drug Metabolism
- 9.Why pKas Matter in Medicinal Chemistry and a Drug Discovery Amine pKa Table
- 10.Phase II Drug Metabolism
- 11.First Disclosures from ACS Chicago 2022
- 12.Topliss Tree and Topliss Scheme Posters
VIEW MORE CONTENT